Clinical and endoscopic aspects of gastroesophageal reflux disease in patients with rheumatic disease

DOI: https://doi.org/10.29296/25877305-2019-05-09
Download full text PDF
Issue: 
5
Year: 
2019

Professor M. Denisov(1), MD; A. Yakushin(1, 3); Professor E. Sarycheva(2), MD; N. Aksenov(1) 1-Novosibirsk National Research State University 2-Novokuznetsk State Institute for Advanced Training of Physicians, Branch, Russian Medical Academy of Continuing Professional Education 3-Center for Family Medicine, Novosibirsk

Thirty-six patients with rheumatic diseases were examined. Clinical signs of gastroesophageal reflux disease were detected in 69.4% of cases; the course of the disease was typical and atypical in 52.8 and 16.7% of patients, respectively. Gastroprotective therapy aimed at resolving the symptoms of the disease or preventing the latter was not performed in 61.1%; endoscopic changes in the mucous membrane of the upper digestive tract were detected in 86.1%, and reflux esophagitis was diagnosed in 13.9%.
Keywords: 
gastroenterology
rheumatic diseases
rheumatoid arthritis
systemic lupus erythematosus
gastroesophageal reflux disease

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Miura Y., Fukuda K., Maeda T. et al. Gastroesophageal reflux disease in patients with rheumatoid arthritis // Mod. Rheumatol. – 2014; 24 (2): 291–5. DOI: 10.3109/14397595.2013.843749.
  2. Nozaki Y., Kinoshita K., Ri J. et al. Estimation of the symptoms for GERD by GerdQ in the patients with rheumatic diseases // Mod. Rheumatol. – 2016; 26 (2): 265–70. DOI:10.3109/14397595.2015.1077556.
  3. Nampei A., Shi K., Ebina K. et al. Prevalence of gastroesophageal reflux disease symptoms and related factors in patients with rheumatoid arthritis // J. Clin. Biochem. Nutr. – 2013; 52 (2): 179–84. DOI: 10.3164/jcbn.12-83.
  4. Bushneva I. G., Shatihin A. I. Ob osobennostjah sochetannogo techenija GERB s IBS, AG, HOBL i RA u lits pozhilogo i starogo vozrasta i voprosy terapii // Biomeditsina. – 2011; 4: 62–4. [Bushneva I.G., Shatikhin A.I. On the singularities of the combined flow of gastroesophageal reflux disease with coronary heart disease, hypertension, chronic obstructive pulmonary disease and rheumatoid arthritis in elderly and old age // Biomeditsina. – 2011; 4: 62–4 (In Russ)].
  5. Karateev A.E., Movsisyan M.M., Anan'eva L.P. i dr. Patologija pischevoda pri sistemnoj sklerodermii: dannye kliniko-endoskopicheskogo obsledovanija // Nauchno-prakticheskaja revmatologija. – 2012; 50 (1): 54–9 [Karateev A.E., Movsisyan M.M., Ananyeva L.P. et al. Esophageal pathology in scleroderma systematica: clinical and endoscopic findings // Rheumatology Science and Practice. – 2012; 50 (1): 54–9 (In Russ)]. https://doi.org/10.14412/1995-4484-2012-505
  6. Brune K., Patrignani P. New insights into the use of currently available non-steroidal anti-inflammatory drugs // J. Pain. Res. – 2015; 8: 105–18. DOI: 10.2147/JPR.S75160.
  7. Kajbysheva V.O., Kucherjavyj Ju.A., Truhmanov A.S. i dr. Rezul'taty mnogotsentrovogo nabljudatel'nogo issledovanija po primeneniju mezhdunarodnogo oprosnika GerdQ dlja diagnostiki gastroezofageal'noj refljuksnoj bolezni // RZhGGK. – 2013; 23 (5): 15–24 [Kaibysheva V.O., Kucheryavyi Yu.A., Trukhmanov A.S. et al. Results of multicenter observation study on application of international questionnaire GerdQ for diagnostics of gastroesophageal reflux disease // RZhGGK. – 2013; 23 (5): 15–24 (In Russ)].
  8. Pshihacheva L.R., Rabadanova A.A. Otsenka rasprostranennosti simptomov gastroezofageal'noj refljuksnoj bolezni u studentov s pomosch'ju oprosnika GerdQ // Molodoj uchenyj. – 2016; 29 (2): 24–5 [Pshikhacheva L.R., Rabadanova A.A. Otsenka rasprostranennosti simptomov gastroezofageal’noi reflyuksnoi bolezni u studentov s pomoshch’yu oprosnika GerdQ // Molodoi uchenyi. – 2016; 29 (2): 24–5 (In Russ)].